Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novel agents with AGE-breaking, AGE-inhibitory and free radical-scavenging activity

March 21, 2003

MicroIslet and Scripps enter islet cell transplantation collaboration

March 20, 2003

Modulators of peroxisome proliferator-activated receptors in Novo Nordisk pipeline

March 20, 2003

Merck KGaA patents new insulin secretagogues

March 20, 2003

Vertex claims novel inhibitors of GSK-3, Aurora-2 and CDK2

March 20, 2003

New GSK-3 inhibitors in early development at Novo Nordisk

March 20, 2003

Acute and subchronic toxicity testing conducted on CJC-1131 in rats and dogs

March 19, 2003

Phase II Alista trial begins recruitment

March 19, 2003

P57 program progresses at Pfizer

March 19, 2003

Merck scientists describe tissue-selective androgen receptor modulators for bone disorders

March 19, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.